Concepedia

Author

Su-Yu Zhu

Peking Union Medical College Hospital

Also Known As

Su-Yu Zhu, SuYu Zhu

11

Publications

649

Citations

10

H-Index

15

Concepts

All Affiliations

Peking Union Medical College HospitalSun Yat-sen University Cancer CenterTianjin Medical University Cancer Institute and HospitalZhejiang Cancer HospitalFujian Provincial Cancer Hospital
SZ

About

Su-Yu Zhu is an author at Peking Union Medical College Hospital specializing in radiation therapy, radiation oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

77

2

Health Sciences

1

1

28

3

Immunology

1

1

49

4

Surgical Oncology

1

1

49

5

Adaptive Radiotherapy

1

1

28

Su-Yu Zhu

×

10

Publications

649

Citations

10

H-Index

YearCitations

Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study

Yong Yang, Yuan Zhu, Jian-Zhong Cao,

Blood

2015

179

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Si-Ye Chen, Yong Yang, Shu‐Nan Qi,

Leukemia

2020

125

Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

Yong Yang, Jian-Zhong Cao, Shengmin Lan,

JAMA Oncology

2016

82

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Shu‐Nan Qi, Yong Yang, Yu-Qin Song,

Blood Advances

2020

56

Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)

Xiu-Wen Deng, Jun-Xin Wu, Tao Wu,

Radiotherapy and Oncology

2018

49

Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma

Xin Liu, Tao Wu, Su-Yu Zhu,

JAMA Network Open

2019

45

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group

Tao Wu, Yong Yang, Su-Yu Zhu,

Blood Advances

2018

32

Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Yong Yang, Ying Wang, Xin Liu,

Leukemia

2020

30

Comparison of three radiotherapy treatment planning protocols of definitive external-beam radiation for localized prostate cancer

Su-Yu Zhu, Takashi Mizowaki, Yasushi Nagata,

International Journal of Clinical Oncology

2005

28

Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)

Wei-Xin Liu, Mei Shi, Hang Su,

Aging

2019

23

Page 1